Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| OPKO HEALTH, INC.OPK · Entity 4891 | Director | June 18, 2026 | June 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
OPKO HEALTH, INC.
Report date June 18, 2026 · Filed June 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.42 · Expires 2036-06-17 | Direct | 30,000 |
Reported balance
After 2026-06-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-18 · Grant · Acquired 30,000 · Balance 30,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 18, 2026 Filed Jun 22, 2026 21:38 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0001193125-26-277749 · ownership.xml · derivative · entry 1 Lachman Prem A · CIK 0001847885 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2036-06-17 Read SEC document |
| April 23, 2025 Filed Apr 23, 2025 21:19 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0000950170-25-057530 · ownership.xml · derivative · entry 1 Lachman Prem A · CIK 0001847885 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2035-04-22 Read SEC document |
| June 22, 2023 Filed Jun 23, 2023 20:14 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001209191-23-039343 · doc4.xml · derivative · entry 1 Lachman Prem A · CIK 0001847885 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-06-21 Read SEC document |
| July 14, 2022 Filed Jul 15, 2022 21:25 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $2.69 | $0.00 |
DisclosureSEC source: 0001209191-22-042276 · doc4.xml · derivative · entry 1 Lachman Prem A · CIK 0001847885 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2032-07-13 Read SEC document |
| June 24, 2021 Filed Jun 25, 2021 12:45 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $3.77 | $0.00 |
DisclosureSEC source: 0001209191-21-043213 · doc4.xml · derivative · entry 1 Lachman Prem A · CIK 0001847885 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2031-06-23 Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:07 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $4.70 | $0.00 |
DisclosureSEC source: 0001209191-21-016807 · doc4.xml · derivative · entry 1 Lachman Prem A · CIK 0001847885 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-02-28 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.